Literature DB >> 12970038

Comparison of three methods for differential cell count in induced sputum.

Beatriz M Saraiva-Romanholo1, Viviani Barnabé, Ana Lúcia I Carvalho, Milton A Martins, Paulo H N Saldiva, Maria do Patrocínio T Nunes.   

Abstract

BACKGROUND: Induced sputum (IS) using the cytospin technique has been extensively employed to characterize inflammatory airway diseases; however, procedures of cell enrichment based on cytospin increase the analytical costs and require slide processing within a short period of time after sampling. STUDY
OBJECTIVES: To compare three different techniques for cytologic analysis of IS, and to determine the time required by each method and the costs involved.
DESIGN: Cross-sectional study.
SETTING: Tertiary-care university hospital. PATIENTS AND MEASUREMENTS: Eighty-nine patients with asthma and 11 subjects without asthma were submitted to increasing hypertonic saline solution concentrations of 2, 3, 4, and 5% for 7 min for sputum induction. Samples were smeared without treatment with 0.1% dithiothreitol (DTT) [technique A], after treatment with DTT (technique B), and after treatment with DTT and cytospin (technique C). All slides were air-dried and stained with Leishman stain. Two independent observers counted at least 200 inflammatory cells on each slide.
RESULTS: Eighty percent of the slides processed by techniques A and B and 65% of the slides processed by technique C represented sputum samples of acceptable quality. The eosinophil percentages in sputum obtained by techniques A and C were closely correlated, as also were those obtained by techniques B and C (r = 0.64 and r = 0.63, respectively; p < 0.01). There was a positive correlation for eosinophils when we compared techniques A and B (r = 0.57, p < 0.01). The neutrophil correlation was significant when the three techniques were compared (technique A vs technique B, r = 0.66; technique A vs technique C, r = 0.51; and technique B vs technique C, r = 0.57; p < 0.01). Bland-Altman analysis showed a good agreement for eosinophil and neutrophil counts when techniques A and B were compared to technique C.
CONCLUSIONS: The three techniques are good indicators of lung inflammation. Techniques A and B are less time consuming and are of lower cost.

Entities:  

Mesh:

Year:  2003        PMID: 12970038     DOI: 10.1378/chest.124.3.1060

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  14 in total

1.  Thick Smear is a Good Substitute for the Thin Smear in Parasitological Confirmation of Canine Visceral Leishmaniasis.

Authors:  Cintia Xavier de Mello; Fabiano Borges Figueiredo; Artur Augusto Velho Mendes Júnior; Luciana de Freitas Campos Miranda; Raquel de Vasconcellos Carvalhaes de Oliveira; Maria de Fátima Madeira
Journal:  Am J Trop Med Hyg       Date:  2016-05-09       Impact factor: 2.345

2.  Reliability of a rapid hematology stain for sputum cytology.

Authors:  Jéssica Gonçalves; Emilio Pizzichini; Marcia Margaret Menezes Pizzichini; Leila John Marques Steidle; Cristiane Cinara Rocha; Samira Cardoso Ferreira; Célia Tânia Zimmermann
Journal:  J Bras Pneumol       Date:  2014 May-Jun       Impact factor: 2.624

3.  Ageing and long-term smoking affects KL-6 levels in the lung, induced sputum and plasma.

Authors:  Nobuhisa Ishikawa; Witold Mazur; Tuula Toljamo; Katri Vuopala; Mikko Rönty; Yasushi Horimasu; Nobuoki Kohno; Vuokko L Kinnula
Journal:  BMC Pulm Med       Date:  2011-05-11       Impact factor: 3.317

4.  Circulating tumor cells measurements in hepatocellular carcinoma.

Authors:  Franck Chiappini
Journal:  Int J Hepatol       Date:  2012-05-28

5.  Fungal contamination of the respiratory tract and associated respiratory impairment among sawmill workers in India.

Authors:  Asit Adhikari; Subhashis Sahu; Arghya Bandyopadhyay; Paul D Blanc; Subhabrata Moitra
Journal:  ERJ Open Res       Date:  2015-10-06

6.  Effect of Anti-IL17 Antibody Treatment Alone and in Combination With Rho-Kinase Inhibitor in a Murine Model of Asthma.

Authors:  Tabata M Dos Santos; Renato F Righetti; Leandro do N Camargo; Beatriz M Saraiva-Romanholo; Luciana R C R B Aristoteles; Flávia C R de Souza; Silvia Fukuzaki; Maria I C Alonso-Vale; Maysa M Cruz; Carla M Prado; Edna A Leick; Milton A Martins; Iolanda F L C Tibério
Journal:  Front Physiol       Date:  2018-09-05       Impact factor: 4.566

7.  Analysis of the sputum and inflammatory alterations of the airways in patients with common variable immunodeficiency and bronchiectasis.

Authors:  Andrea Cristina Pereira; Cristina M Kokron; Beatriz Mangueira Saraiva Romagnolo; Claudia Simeire Albertini Yagi; Paulo Hilário Nascimento Saldiva; Geraldo Lorenzi Filho; Elnara Marcia Negri
Journal:  Clinics (Sao Paulo)       Date:  2009       Impact factor: 2.365

8.  Non-asthmatic patients show increased exhaled nitric oxide concentrations.

Authors:  Beatriz M Saraiva-Romanholo; Fabio S Machado; Francine M Almeida; Maria do Patrocínio T Nunes; Milton A Martins; Joaquim E Vieira
Journal:  Clinics (Sao Paulo)       Date:  2009       Impact factor: 2.365

9.  Effects of Low-Dose and Long-Term Treatment with Erythromycin on Interleukin-17 and Interleukin-23 in Peripheral Blood and Induced Sputum in Patients with Stable Chronic Obstructive Pulmonary Disease.

Authors:  Caimei Tan; Huijuan Huang; Jianquan Zhang; Zhiyi He; Xiaoning Zhong; Jing Bai
Journal:  Mediators Inflamm       Date:  2016-04-03       Impact factor: 4.711

10.  The Plant Proteinase Inhibitor CrataBL Plays a Role in Controlling Asthma Response in Mice.

Authors:  Anelize Sartori Santos Bortolozzo; Adriana Palmeira Dias Rodrigues; Fernanda Magalhães Arantes-Costa; Beatriz Mangueira Saraiva-Romanholo; Flávia Castro Ribas de Souza; Thayse Regina Brüggemann; Marlon Vilela de Brito; Rodrigo da Silva Ferreira; Maria Tereza Dos Santos Correia; Patrícia Maria Guedes Paiva; Carla Máximo Prado; Edna Aparecida Leick; Maria Luiza Vilela Oliva; Milton de Arruda Martins; Viviane Christina Ruiz-Schutz; Renato Fraga Righetti; Iolanda de Fátima Lopes Calvo Tibério
Journal:  Biomed Res Int       Date:  2018-10-01       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.